参考文献/References:
[1] Qin C,Yang S,Chu YH,et al.Signaling pathways involved in ischemic stroke:Molecular mechanisms and therapeutic interventions[J].Signal Transduct Target Ther,2022,7:215.
[2] Xing C,Arai K,Lo EH,et al.Pathophysiologic cascades in ischemic stroke[J].Int J Stroke,2012,7:378-385.
[3] Myers LJ,Perkins AJ,Kilkenny MF,et al.Quality of care and outcomes for patients with acute ischemic stroke and transient ischemic attack during the COVID-19 pandemic[J].J Stroke Cerebrovasc Dis,2022,31:106455.
[4] Xu H,Wang E,Chen F,et al.Neuroprotective phytochemicals in experimental ischemic stroke:Mechanisms and potential clinical applications[J].Oxid Med Cell Longev,2021,2021(4):1-45.
[5] 李丽容,卢治兰,邓向海,等.2型糖尿病患者并发缺血性脑卒中危险因素及与载脂蛋白E基因型相关性分析[J].陕西医学杂志,2021,50(6):723-725,730.
[6] Zhang X,Zeng W,Zhang Y,et al.Focus on the role of mitochondria in NLRP3 inflammasome activation:A prospective target for the treatment of ischemic stroke(Review)[J].Int J Mol Med,2022,49(6):74.
[7] 王 逍,屈阳柳,胡雪纯,等.通脉舒络胶囊对缺血性中风大鼠Th17细胞介导炎症反应的影响[J].陕西中医,2022,43(9):1185-1190.
[8] Reeves MJ,Bushnell CD,Howard G,et al.Sex differences in stroke:Epidemiology,clinical presentation,medical care,and outcomes[J].Lancet Neuro,2008,7:915-926.
[9] Bao Z,Zhang Z,Zhou G,et al.Novel mechanisms and therapeutic targets for ischemic stroke:A focus on gut microbiota[J].Front Cell Neurosci,2022,16:871720.
[10] Prossnitz ER,Arterburn JB.International union of basic and clinical pharmacology.XCVⅡ.G Protein-Coupled estrogen receptor and its pharmacologic modulators[J].Pharmacol Revs,2015,67:505-540.
[11] Zhao TZ,Ding Q,Hu J,et al.GPER expressed on microglia mediates the anti-inflammatory effect of estradiol in ischemic stroke[J].Brain Behav,2016,6:e00449.
[12] Fisher M,Saver JL.Future directions of acute ischaemic stroke therapy[J].Lancet Neurol,2015,14:758-767.
[13] Liu L,Wang D,Wong KS,et al.Stroke and stroke care in China:Huge burden,significant workload,and a national priority[J].Stroke,2011,42:3651-3654.
[14] Xu S,Lu J,Shao A,et al.Glial cells:Role of the immune response in ischemic stroke[J].Front Immunol,2020,11:294.
[15] Qiu YM,Zhang CL,Chen AQ,et al.Immune cells in the BBB Disruption after acute ischemic stroke:Targets for immune therapy?[J].Front Immunol,2021,12:678744.
[16] Liu ZJ,Ran YY,Qie SY,et al.Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti-inflammatory phenotype through STAT3 pathway[J].CNS Neurosci Ther,2019,25:1353-1362.
[17] Yamazaki T,Ushikoshi-Nakayama R,Shakya S,et al.The effects of bathing in neutral bicarbonate ion water[J].Sci Rep,2021,11:21789.
[18] Onose G,Anghelescu A,Blendea D,et al.Cellular and molecular targets for non-invasive,non-pharmacological therapeutic/rehabilitative interventions in acute ischemic stroke[J].Int J Mol Sci,2022,23(2):907.
[19] Mollet I,Marto JP,Mendonca M,et al.Remote but not distant:A review on experimental models and clinical trials in remote ischemic conditioning as potential therapy in ischemic stroke[J].Mol Neurobiol,2022,59:294-325.
[20] Jayaraj RL,Azimullah S,Beiram R,et al.Neuroinflammation:Friend and foe for ischemic stroke[J].J Neuroinflammation,2019,16:142.
[21] Maddahi A,Edvinsson L.Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway[J].J Neuroinflammation,2010,7:14.
[22] Simao F,Matte A,Pagnussat AS,et al.Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3beta and CREB through PI3-K/Akt pathways[J].Eur J Neurosci,2012,36:2899-2905.
[23] Bigarre IM,Trombetta BA,Guo YJ,et al.IGF2R circular RNA hsa_circ_0131235 expression in the middle temporal cortex is associated with AD pathology[J].Brain Behav,2021,11:e02048.
[24] Li YF,Ren LN,Guo G,et al.Endothelial progenitor cells in ischemic stroke:An exploration from hypothesis to therapy[J].J Hematol Oncol,2015,8:33.
[25] Zhu X,Yan J,Bregere C,et al.RBM3 promotes neurogenesis in a niche-dependent manner via IMP2-IGF2 signaling pathway after hypoxic-ischemic brain injury[J].Nat Commun,2019,10:3983.
[26] Aberg D,Aberg ND,Jood K,et al.Insulin-like growth factor-ii and ischemic stroke-a prospective observational study[J].Life(Basel),2021,11(6):499.
[27] Denorme F,Portier I,Rustad JL,et al.Neutrophil extracellular traps regulate ischemic stroke brain injury[J].J Clin Invest,2022,132(10):e154225.
[28] Jickling GC,Liu D,Ander BP,et al.Targeting neutrophils in ischemic stroke:Translational insights from experimental studies[J].J Cereb Blood Flow Metab,2015,35:888-901.
[29] Pemberton K,Rosato M,Dedert C,et al.Differential effects of the G-protein-coupled estrogen receptor(GPER)on rat embryonic(E18)hippocampal and cortical neurons[J].eNeuro,2022,9(4):475-521.
[30] Prossnitz ER.GPER modulators:Opportunity noxon the heels of a class Akt[J].J Steroid Biochem Mol Biol,2018,176:73-81.
相似文献/References:
[1]蔺雪梅,王 芳,王 静,等.RRE90、ESRS和SPIⅡ评分对缺血性脑卒中复发风险预测价值比较*[J].陕西医学杂志,2019,(5):599.
LIN Xuemei,WANG Fang,WANG Jing,et al.Comparison of predictive value of RRE90, ESRS, and SPIII scores for recurrent risk in ischemic stroke patients[J].,2019,(4):599.
[2]贾小慧,王泽宇,田嘉莹,等.丹参酮ⅡA通过抑制细胞色素P450 1B1/长链酰基辅酶A合成酶4通路介导铁死亡缓解缺血性脑卒中[J].陕西医学杂志,2025,54(7):882.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.003]
JIA Xiaohui,WANG Zeyu,TIAN Jiaying,et al.Tanshinone ⅡA alleviates ischemic stroke by suppressing cytochrome P450 1B1/acyl-CoA synthetase long-chain family member 4 (CYP1B1/ACSL4)-mediated ferroptosis[J].,2025,54(4):882.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.003]
[3]熊英琼,江铃铃,彭毓棻,等.基于磷脂酰肌醇3激酶/蛋白激酶B信号通路探究麦冬皂苷D对脑缺血再灌注损伤的神经保护作用[J].陕西医学杂志,2026,(1):35.[doi:DOI:10.3969/j.issn.1000-7377.2026.01.006]
XIONG Yingqiong,JIANG Lingling,PENG Yufen,et al.Exploring the neuroprotective effect of ophiopogonin D on cerebral ischemia-reperfusion injury based on the PI3K/AKT signaling pathway[J].,2026,(4):35.[doi:DOI:10.3969/j.issn.1000-7377.2026.01.006]
[4]陈传立,王 建.低温治疗缺血性脑卒中的神经保护机制研究进展[J].陕西医学杂志,2026,(5):697.[doi:DOI:10.3969/j.issn.1000-7377.2026.05.022]
CHEN Chuanli,WANG Jian.Research progress on the neuroprotective mechanisms of hypothermia therapy for ischemic stroke[J].,2026,(4):697.[doi:DOI:10.3969/j.issn.1000-7377.2026.05.022]